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Abstract
Background
With the rise in fluoroquinolone-resistant Salmonella Typhi and the recent emergence of cef-
triaxone resistance, azithromycin is one of the last oral drugs available against typhoid for
which resistance is uncommon. Its increasing use, specifically in light of the ongoing out-
break of extensively drug-resistant (XDR) Salmonella Typhi (resistant to chloramphenicol,
ampicillin, cotrimoxazole, streptomycin, fluoroquinolones and third-generation cephalospo-
rins) in Pakistan, places selective pressure for the emergence and spread of azithromycin-
resistant isolates. However, little is known about azithromycin resistance in Salmonella, and
no molecular data are available on its mechanism.
Methods and findings
We conducted typhoid surveillance in the two largest pediatric hospitals of Bangladesh from
2009–2016. All typhoidal Salmonella strains were screened for azithromycin resistance
using disc diffusion and resistance was confirmed using E-tests. In total, we identified 1,082
Salmonella Typhi and Paratyphi A strains; among these, 13 strains (12 Typhi, 1 Paratyphi
A) were azithromycin-resistant (MIC range: 32–64 μg/ml) with the first case observed in
2013. We sequenced the resistant strains, but no molecular basis of macrolide resistance
was identified by the currently available antimicrobial resistance prediction tools. A whole
genome SNP tree, made using RAxML, showed that the 12 Typhi resistant strains clustered
together within the 4.3.1.1 sub-clade (H58 lineage 1). We found a non-synonymous single-
point mutation exclusively in these 12 strains in the gene encoding AcrB, an efflux pump that
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removes small molecules from bacterial cells. The mutation changed the conserved amino
acid arginine (R) at position 717 to a glutamine (Q). To test the role of R717Q present in azi-
thromycin-resistant strains, we cloned acrB from azithromycin-resistant and sensitive
strains, expressed them in E. coli, Typhi and Paratyphi A strains and tested their azithromy-
cin susceptibility. Expression of AcrB-R717Q in E. coli and Typhi strains increased the mini-
mum inhibitory concentration (MIC) for azithromycin by 11- and 3-fold respectively. The
azithromycin-resistant Paratyphi A strain also contained a mutation at R717 (R717L),
whose introduction in E. coli and Paratyphi A strains increased MIC by 7- and 3-fold respec-
tively, confirming the role of R717 mutations in conferring azithromycin resistance.
Conclusions
This report confirms 12 azithromycin-resistant Salmonella Typhi strains and one Paratyphi
A strain. The molecular basis of this resistance is one mutation in the AcrB protein at position
717. This is the first report demonstrating the impact of this non-synonymous mutation in
conferring macrolide resistance in a clinical setting. With increasing azithromycin use,
strains with R717 mutations may spread and be acquired by XDR strains. An azithromycin-
resistant XDR strain would shift enteric fever treatment from outpatient departments, where
patients are currently treated with oral azithromycin, to inpatient departments to be treated
with injectable antibiotics like carbapenems, thereby further burdening already struggling
health systems in endemic regions. Moreover, with the dearth of novel antimicrobials in the
horizon, we risk losing our primary defense against widespread mortality from typhoid. In
addition to rolling out the WHO prequalified typhoid conjugate vaccine in endemic areas to
decrease the risk of pan-resistant Salmonella Typhi strains, it is also imperative to imple-
ment antimicrobial stewardship and water sanitation and hygiene intervention to decrease
the overall burden of enteric fever.
Author summary
With the outbreak of extensively resistant (XDR) typhoid fever in Pakistan, azithromycin
has become the last oral drug to treat typhoid. Although no azithromycin resistant XDR
isolate has been reported to date, the increasing use of azithromycin and the clear histori-
cal record of widespread dissemination of resistance to all previously widely used antimi-
crobials by typhoidal Salmonella, suggest we will soon face strains resistant to all oral
antibiotics. This makes it imperative to elucidate the mechanism of azithromycin resis-
tance in typhoidal Salmonella. We tested 1,082 typhoidal Salmonella isolates from the two
largest pediatric hospitals of Bangladesh and identified 13 azithromycin-resistant isolates.
Using comparative genomics, we identified a mutation in a specific protein called AcrB
that makes these isolates resistant to azithromycin. All azithromycin-resistant strains were
susceptible to cephalosporin but resistant to all other oral antibiotics. The Pakistan out-
break strain is resistant to all common oral antibiotics and only susceptible to azithromy-
cin. Acquisition of the plasmid that confers cephalosporin resistance in XDR strains by
the Bangladeshi azithromycin-resistant strains or rise of the AcrB mutation in the XDR
strains could be the end of oral treatment for typhoid. This poses serious threats to the
health system of LMICs where typhoid is endemic. Currently, the majority of typhoid
patients are prescribed oral treatment in the outpatient department, but an azithromycin-
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resistant XDR strain would shift enteric fever treatment from outpatient departments to
inpatient departments to be treated with injectable antibiotics like carbapenems, further
burdening already struggling health systems in endemic regions. Moreover, with the
dearth of novel antimicrobials in the horizon, we risk losing our primary defense against
widespread mortality from enteric fever.
Introduction
Typhoid and paratyphoid, collectively known as enteric fever, are among the most common
bacterial causes of morbidity worldwide, with the greatest burden in low- and middle-income
countries [1]. Salmonella enterica subspecies enterica serovars Typhi (Salmonella Typhi) and
Paratyphi (A, B and C), etiologies of enteric fever, cause an estimated 14 million illnesses and
136,000 deaths annually.
In the pre-antibiotic era, enteric fever mortality rates exceeded 30% in many areas, but
ampicillin, chloramphenicol and co-trimoxazole were instrumental in reducing the rates to
<1%. Resistance to all three antibiotics (referred to as multidrug resistance, MDR) emerged
in late 1980’s [2], predominantly due to the rise and subsequent continental migration of
H58 haplotype (now referred to as 4.3.1), which contained the resistance genes either on
IncH1 plasmids or integrated within the chromosome [3–6]. Fluoroquinolones soon
became the most-commonly prescribed antibiotic [7], but since the 2000’s there have been
increasing reports of decreased fluoroquinolone susceptibility due to the acquisition of
chromosomal mutations in the DNA gyrase and topoisomerase IV genes [8–13]. In Bangla-
desh, >99% of all Typhi and Paratyphi A strains exhibit decreased susceptibility to cipro-
floxacin [14]. Based on the rising trends of fluroquinolone resistance, in 2011, WHO
recommended ceftriaxone or azithromycin for treating Salmonella Typhi non-susceptible
to fluoroquinolones [15].
The first report of ceftriaxone resistance emerged from Bangladesh in 2001, and since then
there have been only sporadic reports of ceftriaxone-resistant Salmonella Typhi strains [16,17].
However, in 2016, an outbreak of extensively drug-resistant (XDR) Salmonella Typhi, resistant
to chloramphenicol, ampicillin, cotrimoxazole, streptomycin, fluoroquinolones and third-gen-
eration cephalosporins was recognized in Pakistan and to date over 5000 cases have been con-
firmed [18,19]. Cephalosporin resistance of the XDR strains was caused by the acquisition of a
broad-spectrum beta-lactamase resistance gene (bla-CTX-M-15) on an IncY plasmid found in
E. coli isolates. Typhoid patients in Pakistan are primarily being treated in the out-patient
department with the last available oral option, the macrolide azithromycin, resistance to which
is uncommon [20]. This increasing use of azithromycin places selective pressure for the emer-
gence and spread of azithromycin-resistant isolates, raising concerns of untreatable infections
and increased mortality rates. Little is known about azithromycin resistance in typhoidal Sal-
monella; while there are some sporadic reports on azithromycin treatment failures [4,21–23],
there are no data on the molecular mechanism of resistance.
In Bangladesh, Salmonella Typhi and Paratyphi A are the most common causes of blood-
stream infections in children over 2 months of age and comprise of two-third of blood-cul-
ture positive isolates in microbiology laboratories [24]. Leveraging our surveillance system
in place for enteric fever [25], here we describe the presence of azithromycin resistance
among typhoidal Salmonella in Bangladesh and identify the molecular basis behind this
resistance.
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Methods
Study site and population
In this study, we report data from enteric fever surveillance conducted in the inpatient depart-
ments of the two largest pediatric hospitals of Bangladesh, Dhaka Shishu (Children) Hospital,
DSH, and Shishu Shasthya (Child Health) Foundation Hospital, SSFH. These are sentinel sites
of the World Health Organization supported Invasive Bacterial Vaccine Preventable Diseases
surveillance platform in Bangladesh.
Patient enrollment, etiology detection and antibiogram
Blood culture was performed at the discretion of the treating physicians. We enrolled patients
with positive blood cultures for Salmonella Typhi or Paratyphi A. Blood cultures were per-
formed using standard methods [24]. We aseptically obtained 2–3 milliliters of blood, which
was inoculated into trypticase soy broth supplemented with sodium polyanethole sulphonate
(0.25%) and isovitalex (1%). Incubated blood culture bottles were sub-cultured on the second,
third, and fifth days of incubation. Identification of Salmonella Typhi/Paratyphi A isolates was
confirmed using standard biochemical tests and agglutination with Salmonella species and ser-
ovar-specific antisera (Ramel, Thermo Fisher Scientific). Laboratory methods for blood culture
and organism identification were consistent over the reporting period.
We used disc diffusion methods for determining antibiotic susceptibility patterns for azi-
thromycin, ampicillin, co-trimoxazole, chloramphenicol, ciprofloxacin, levofloxacin, ceftriax-
one, cefepime, cefixime and ceftazidime (Oxoid, Thermo Scientific, MA, USA). Azithromycin
e-strips (bioMérieux, France) were used to determine the minimum inhibitory concentration
(MIC) and confirm azithromycin resistance for strains that exhibited zone of clearance�12
mm in the presence of azithromycin discs. All results were interpreted according to the latest
Clinical and Laboratory Standards Institute guidelines 2018 [26].
DNA extraction and whole genome sequencing
We conducted whole genome sequencing on all identified azithromycin-resistant strains (12
Salmonella Typhi and 1 Paratyphi A). Isolates were grown on MacConkey agar (Oxoid, UK)
overnight and DNA was extracted from a suspension of the overnight culture using the
QIAamp DNA minikit (Qiagen, Hilden, Germany). Whole genome sequencing was per-
formed on the Illumina HiSeq 4000 platform to generate 150 bp paired-end reads (Novogene
Co. Ltd., Beijing, China). We used SPAdes 3.11.1 [27] to assemble the short paired-end reads
into contigs for downstream analyses. All the sequences have been submitted to EnteroBase
and NCBI (BioProject ID: PRJNA528114).
Bioinformatics analysis
For comparative genomic analysis, we compared the 12 azithromycin-resistant Salmonella
Typhi strains with 536 strains that were previously isolated and genetically characterized by
our group in Bangladesh [28]. Using the ParSNP tool [29], we constructed whole-genome SNP
tree for 12 azithromycin resistant Salmonella Typhi strains with 536 strains from Tanmoy
et al. [28]. Salmonella Typhi CT18 was used as the reference strain and Salmonella Typhimur-
ium strain LT2 was used as the outgroup. SNPs present in genomic regions undergoing
recombination were removed using the phipack package within the ParSNP tool. The final
phylogenetic tree was obtained through RAxML (RAxML-NG v0.9.0) [30] with generalized
time-reversible model and a Gamma distribution to model site-specific rate variation (GTR+
Γ substitution model) with 100 bootstraps to assess branch support. The genotypes were
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obtained using the Genotyphi script [6]. ggtree was used for tree visualization and overlaying
the genotype data [31]. SRST2 0.2.0 [32], ResFinder [33] and CARD [34] were used to predict
antimicrobial resistance markers, and PlasmidFinder [35] to identify the putative plasmids
present in these strains. Finally, we compared the resistant strains to all sensitive Salmonella
Typhi strains manually to find SNPs exclusive to the resistant strains (comparison to the most
closely related 5 genomes are shown in Fig 1C) using the Gingr tool from the Harvest suite
v1.1.2 [29]. To predict the function of the SNPs on protein function, we examined the protein
structure (PDB ID: 3AOC) on PyMOL [36].
Fig 1. Emergence of azithromycin-resistant strains of Salmonella Typhi in Bangladesh and their genomic analysis. (A) Temporal distribution of 939 Salmonella
Typhi isolates included in the study. The number of isolates is shown as the line plot from 2009–2016. The numbers of azithromycin-resistant strains isolated each year
is shown in the bar plot. Azithromycin-resistant strains were first isolated in 2013. (B) Whole-genome SNP tree of 548 Salmonella Typhi strains isolated in Bangladesh
including 12 strains from the present study and 536 strains from a previous study [28]. The tree highlights the different genotypes that are found in Bangladesh
including the most prevalent genotype 4.3.1.1 (H58 lineage 1). The 12 azithromycin-resistant strains (colored in red) clustered together within the genotype 4.3.1.1.
Salmonella Typhimurium strain LT2 was used as an outgroup, while Salmonella Typhi strain CT18 was used as the reference strain. (C) Predicted and experimentally
determined antimicrobial susceptibility pattern of azithromycin-resistant Salmonella Typhi strains and the most-closely related five azithromycin-sensitive strains. The
antimicrobial susceptibility was experimentally determined through disc diffusion assay against a panel of 10 antibiotics. The predicted transmissible elements and
antimicrobial resistance markers are also shown.
https://doi.org/10.1371/journal.pntd.0007868.g001
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To determine the lineage of the azithromycin resistant Salmonella Paratyphi A strain 3144,
we used 66 strains from Britto et al. [6] and 73 strains from Kuijpers et al. [37] that were found
on Enterobase [38]. In this case, Salmonella Paratyphi A strain AKU_12601 was used as the
reference strain and Salmonella Typhi strain CT18 was used as the outgroup. SNPs present in
genomic regions undergoing recombination was removed using the phipack package within
ParSNP tool. The final phylogenetic tree was obtained through RAxML (RAxML-NG v0.9.0)
[30] with generalized time-reversible model and a Gamma distribution to model site-specific
rate variation (GTR+ Γ substitution model) with 100 bootstraps to assess branch support. The
lineage information for the 140 strains were obtained from Britto et al. [6] and Kuijpers et al.
[37], and ggtree was used to visualize the phylogenetic tree and overlay the lineage
information.
Macrolide susceptibility test in E. coli and Salmonella Typhi
We amplified the acrB genes from azithromycin-resistant Salmonella Typhi strain 5003
(SAMN11174925) and Paratyphi A strain 3144 (SAMN11174919) and azithromycin-sensitive
Typhi strain 4119 and Paratyphi A strain 4071 using PCR with forward and reverse primers
with overhangs complementary to pHERD30T (TAAAACGACGGCCAGTGCCAAGCTT
TCAGCGATGTTCTGTCGAATGAC and TAAAACGACGGCCAGTGCCAAGCTTTCA
ATGATGATCGACAGTATGGCTG respectively). The genes were inserted into the multiple
cloning site of pHERD30T using Gibson assembly [39]. We verified the sequences of all
inserted genes through Sanger sequencing. The plasmids were chemically transformed into
CaCl2-competent E. coli BW25112 ΔacrB strains obtained from the Keio collection [40], and
electroporated into Typhi strain 4119 and Paratyphi A strain 4071. E. coli strains with plasmids
(with or without an insert) were tested for susceptibility patterns for erythromycin, azithromy-
cin, ampicillin, co-trimoxazole, chloramphenicol, ciprofloxacin, levofloxacin, ceftriaxone, cefe-
pime, cefixime and ceftazidime using the disc diffusion method, and MIC was determined
using azithromycin E-strips. Typhi and Paratyphi A strains with plasmids (with or without an
insert) were tested for susceptibility patterns for azithromycin using E-strips.
Ethical clearance
The protocols were approved by the ethics review committees of the Bangladesh Institute of
Child Health, DSH. Blood samples were collected and received at the laboratory as part of rou-
tine clinical care and informed written consent was obtained from parents or caregivers for
other aspects of the study, including data collection and use of specimens for additional labora-
tory analysis.
Results
Emergence of azithromycin-resistant Salmonella Typhi and Paratyphi A
Between 2009 and 2016, through our enteric fever surveillance [24] in the inpatient depart-
ments of the two largest pediatric hospitals of Bangladesh, we isolated 939 Salmonella Typhi
and 143 Paratyphi A strains. Twelve of the Typhi and one of the Paratyphi A strains were resis-
tant to azithromycin, with disc diameters of�12 mm, and minimum inhibitory concentration
(MIC) of�32 μg/ml [41]. All 12 azithromycin-resistant Salmonella Typhi strains were also
MDR and were increasingly isolated since 2013 (Fig 1A), marking gradual emergence of azi-
thromycin-resistant Salmonella Typhi in Bangladesh. All patients with azithromycin-resis-
tance typhoid or paratyphoid lived in Dhaka city, known to be endemic for enteric fever
[14,24,25,42] (S1 Fig).
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Azithromycin resistant Salmonella Typhi harbors a mutation in the AcrB
efflux pump
We sequenced the 12 azithromycin-resistant Typhi strains and found that all azithromycin-
resistant strains belonged to genotype 4.3.1.1 (H58 lineage 1), the most common genotype
found in Bangladesh [4,28]. In a whole-genome single nucleotide polymorphism (SNP) tree,
the 12 strains clustered together indicating that they are genetically similar to one another and
potentially arose for a single common ancestral strain (Fig 1B, S1 Table). To identify the
genetic basis of azithromycin resistance, we used three bioinformatic tools: SRST2 [32], Resfin-
der [33] and CARD [34] and to evaluate the results obtained from these tools, we tested anti-
microbial susceptibility against a panel of nine other antibiotics (Fig 1C, S1 Table). While the
tools successfully predicted the observed susceptibility patterns for the nine antibiotics, no
known azithromycin resistance mechanism was identified (Fig 1C). Using PlasmidFinder [35]
we identified two mobile genetic elements in these Salmonella Typhi strains: (i) repC (12/12
strains), a ~24kbp Tn2670-like or SGI11-like complex transposable element carrying AMR
genes which is found commonly in isolates and is integrated into the chromosome [4], and (ii)
IncFIB (11/12 strains) on plasmid pHCM2 commonly found in Salmonella Typhi strains but
not known to harbor AMR genes [43,44]. Both these mobile elements were also present in
closely related azithromycin-sensitive strains. The lack of known azithromycin-resistance
genes indicated a novel mechanism of azithromycin resistance in these strains.
We compared the sequences of these 12 azithromycin-resistant strains to that of 536 Typhi
strains that we had previously sequenced and genetically characterized [28]. In the WGS SNP
tree, we identified four unique SNPs, present only in the 12 azithromycin-resistant strains,
three of which were non-synonymous: STY2741 (codes for PurN, a glycinamidine ribonucle-
otide transformyltransferase), STY1399 (codes for a hypothetical protein) and STY0519
(codes for AcrB, an inner membrane permease) (Fig 2A, S2 Fig). For the first two candidates,
there is no evidence of their involvement in mediating antimicrobial resistance in the litera-
ture. However, the third gene, acrB is part of a trans-envelope resistance-nodulation-division
(RND) efflux pump that has been previously reported to transport macrolides including azi-
thromycin across the bacterial cell envelope, making it the most promising candidate [45].
Mutations affecting expression of AcrB have been implicated in macrolide resistance in Neis-
seria gonorrhoeae [46]. Furthermore, laboratory mutagenesis studies in Escherichia coli have
shown that mutations in acrB can lead to higher macrolide efflux thereby contributing to
resistance [47]. The SNP observed in the 12 azithromycin-resistant Salmonella Typhi strains
changed the arginine residue (R) at position 717 to a glutamine (Q) (Fig 2B). R717 is a con-
served residue on the periplasmic cleft that acts as the entry portal for most drugs in AcrB
(Fig 2C).
R717 mutations in AcrB confer azithromycin resistance
We cloned acrB from azithromycin susceptible and resistant Salmonella Typhi strains into an
E. coli plasmid and introduced them into an E. coli strain that lacks the endogenous acrB (E.
coli ΔacrB). Compared to E. coli strains containing empty plasmid or wild type acrB, the strain
expressing AcrB-R717Q showed a smaller zone of disc clearance for both azithromycin (26.3
mm vs 16.7 mm, p = 0.0013) and erythromycin discs (22.3 mm vs 11.7 mm, p value = 0.0009)
and exhibited a 11-fold increase in azithromycin MIC (0.22 μg/ml vs 2.7 μg/ml, p = 0.0002)
(Fig 3A and 3B). Certain AcrB mutations have previously been shown to effect transport of
other antibiotics such as ciprofloxacin [48], but the R717Q mutation did not change the sus-
ceptibility patterns for any other nine antibiotics we tested, indicating the specificity of this
mutation towards azithromycin resistance (S2 Table). For further confirmation of the effects
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of this mutation in Salmonella Typhi, we introduced the plasmids in an azithromycin-sensitive
Typhi strain and observed a 3-fold increase in MIC (5 μg/ml vs 13 μg/ml, p< 0.0001) in the
presence of AcrB-R717Q (Fig 3C). The difference here is lower compared to that seen in E. coli
ΔacrB plausibly because the Typhi strain contains endogenous wild-type AcrB competing
against the exogenous AcrB-R717Q that we artificially introduced. Taken together, these
results confirm that AcrB-R717Q specifically leads to increased macrolide resistance.
Fig 2. Identification of R717Q mutation on AcrB efflux pump as a cause of azithromycin resistance in Salmonella Typhi. (A) Whole genome sequence alignment
of 12 azithromycin-resistant and 5 most genetically similar azithromycin-sensitive Salmonella Typhi strains (identified in the phylogenetic tree in Fig 1B). Whole
genome SNP detection and alignment was done using ParSNP and results were visualized in Gingr [29]. The single nucleotide polymorphisms (SNPs) unique to the
resistant strains are highlighted with vertical lines. Four SNPs were identified: 3 non-synonymous (shown as a red line) and 1 synonymous SNPs (shown as a green line)
that are exclusive to the azithromycin resistant strains. (B) The acr gene cluster in Salmonella Typhi reference strain CT18. One of the SNPs found exclusively in
azithromycin-resistant strains was mapped to the gene cluster composed of: acrA (STY0520) and acrB (STY0519), that encodes a periplasmic and inner membrane
protein component of the RND-efflux pumps respectively, and acrR (STY0521), a transcriptional regulator of AcrA/B protein synthesis. The SNP was present on the
acrB gene and resulted in the change of an arginine (R) at position 717 to a glutamine (Q) residue on the encoded AcrB protein (highlighted in yellow). (C) R717Q
mutation is present at the periplasmic cleft of the proximal binding pocket on AcrB. Structure of E. coli AcrB (PDB ID: 3AOC) is shown in green with the macrolide
erythromycin bound in the proximal drug binding pocket. AcrB is present in the inner membrane (IM) of the bacterial cells and drug molecules, including macrolides,
enter the AcrB pump through a periplasmic opening that leads to a proximal binding pocket. The drug molecules are shuttled outside the cells through the proximal
binding pocket with the help of the proton motive force. R717 lines the entry of the periplasmic opening.
https://doi.org/10.1371/journal.pntd.0007868.g002
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We conducted an extensive BLAST search to identify other typhoidal Salmonella strains
with mutations in AcrB the NCBI database and found only one Salmonella Typhi strain iso-
lated in Oceania in 2008 (Typhi_10349_1#30, genotype 3.5.4, a non-MDR strain that contains
gyrA D87N) that contained the same R717Q mutation, however no AMR data were available
for this strain. Interestingly, whole genome sequencing of the one azithromycin-resistant Sal-
monella Paratyphi A strain (lineage C4, S3 Fig) identified during our surveillance showed that
this strain also contained a mutation in acrB which changed R717 to a leucine (L) (Fig 4A).
This mutation was absent in the genomes of the Paratyphi A strains in the NCBI database. To
determine the effect of R717L mutation, we expressed Paratyphi A wild-type AcrB and
AcrB-R717L in E. coli ΔacrB (Fig 4B and 4C). As seen for Typhi AcrB R717Q, Paratyphi A
AcrB-R717L leads to a smaller disc clearance for azithromycin (26.3 mm vs 16.3 mm, p =
0.0001) and erythromycin (22.4 mm vs 11.4 mm, p = 0.0001) and 10-fold higher azithromycin
MIC (0.22 μg/ml vs 2.5 μg/ml, p = 0.003). When these plasmids were introduced in a sensitive
Paratyphi A strain, we observed 4-fold change in MIC (7 μg/ml vs 28 μg/ml, p = 0.0001) in the
presence of the R717L mutation, confirming that mutations in R717 lead to macrolide
resistance.
Fig 3. AcrB R717Q increases efflux of macrolides in E. coli and Salmonella Typhi strains. Quantification of results obtained from three biological replicates for (A)
disc diffusion and (B) E-strip assays are shown for E. coli BW25113 ΔacrB transformed with different plasmids. (C) Quantification of results obtained from at least three
biological replicates from azithromycin E-strip assay in Typhi strain 4119. One way-ANOVA with multiple comparisons was used to test statistical significance. ns:
p>0.05; ��: p� 0.01; ���: p� 0.001, ����: p� 0.0001.
https://doi.org/10.1371/journal.pntd.0007868.g003
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Fig 4. Identification of R717L mutation in AcrB protein in Salmonella Paratyphi A strains. (A) Sequence alignment of acrB gene from the azithromycin-resistant
Salmonella Paratyphi A strain to the acrB gene (spa2247) in the reference strain ATCC 9150. A SNP was identified that changed the R717 to a leucine (L) residue
(highlighted in yellow). Quantification of results obtained from three biological replicates for (B) disc diffusion and (C) E-strip assays in E. coli are shown. (D)
Quantification of results obtained from at least three biological replicates from azithromycin E-strip assay in Paratyphi A strain 4071 is shown. One way-ANOVA with
multiple comparisons was used to test statistical significance. ns: p>0.05; ��: p� 0.01; ����: p� 0.0001.
https://doi.org/10.1371/journal.pntd.0007868.g004
Azithromycin resistance in typhoidal Salmonella
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0007868 November 15, 2019 10 / 16
Discussion
Rising antimicrobial resistance threatens the progress made so far in management of enteric
fever. In this study, we report the gradual rise of resistance amongst typhoidal Salmonella in
Bangladesh to azithromycin, the last available oral antibiotic to treat enteric fever. We identi-
fied 12 azithromycin-resistant Salmonella Typhi strains and one Paratyphi A strain. The
molecular basis of this resistance is one mutation in the RND efflux pump AcrB protein at
position 717 and this is the first report demonstrating the impact of this mutation in confer-
ring macrolide resistance in a clinical setting.
AcrB has not been previously implicated in macrolide resistance in Salmonella. However,
previous work has shown that mutations of AcrB or changes in its expression can lead to resis-
tance in Neisseria gonorrhoeae and Escherichia coli, but the specific mutation at position 717 is
not predicted to confer antibiotic resistance in any available antibiotic resistant prediction tools
[46,47]. The SNP we observed in the 12 azithromycin-resistant Salmonella Typhi strains
changed the arginine residue (R) at position 717 to a glutamine (Q), while in the azithromycin-
resistant Salmonella Paratyphi A strain the same arginine residue was changed to a leucine (L).
The arginine at position 717 is a conserved residue on the periplasmic cleft that acts as the entry
portal for most drugs in AcrB. Change of a large positively charged arginine to a smaller gluta-
mine or leucine may affect the movement of macrolides into the drug pocket, which in turn
may affect their subsequent efflux via AcrB. Interestingly, in a previous mutagenesis study, sub-
stitution of the arginine residue with an alanine (R717A) was found to partially increase efflux
of the macrolide erythromycin in E. coli [49]. Furthermore, a recent study using molecular
dynamics simulation showed that AcrB R717L mutation increases the uptake of macrolides into
the drug pocket, increasing azithromycin resistance in Salmonella Typhimurium in vitro [50].
Azithromycin is widely used empirically in hospitals and sold over the counter in Bangladesh
since 1995. Azithromycin and third generation cephalosporins like cefixime are currently the most
common empirical drug used for treatment of febrile illnesses including enteric fever in the out-
patient departments and community. Although the rate of azithromycin resistance of typhoidal Sal-
monella in Bangladesh is low and the genetic basis is a chromosomal SNP, in light of the outbreak
of XDR typhoid in Pakistan, increased azithromycin use can place selective pressure on strains such
as the ones with R717 mutations to spread. Although no azithromycin resistant XDR isolate has
been reported to date, the increasing use of azithromycin and the clear historical record of wide-
spread dissemination of resistance to all previously widely used antimicrobials by Salmonella Typhi
and Paratyphi A [3,4,44] suggest we will soon face strains resistant to almost all oral antibiotics.
There have been two reports of ceftriaxone-resistant Salmonella Typhi from Bangladesh to
date [16,17]. Acquisition of the plasmid that confers ceftriaxone resistance in XDR strains by
the Bangladeshi azithromycin-resistant strains will bring us to brink of the end of oral treat-
ment for typhoid. Similarly, the rise of a point mutation like R717Q in AcrB in the XDR Typhi
outbreak strain of Pakistan will be catastrophic. In endemic countries like Bangladesh and
Pakistan, typhoidal Salmonella is the primary etiology of bloodstream infections. Currently the
majority of typhoid patients are prescribed oral treatment in the outpatient department and
sent home, but an azithromycin-resistant XDR strain would shift enteric fever treatment from
outpatient departments, to inpatient departments to be treated with injectable antibiotics like
carbapenems, thereby further burdening an already struggling health systems in endemic
regions [51,52]. For example, in Dhaka Shishu Hospital, each year 23,000 children are admit-
ted, and about 6,000 children are refused admission because of lack of available beds, despite
being the largest pediatric hospital [52]; hundreds of thousands of children are treated in the
out-patient department and sent home. This situation will be much worsened if the option for
out-patient based oral treatment of typhoid is not available.
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The findings of this study should be considered within the context of a few limitations. The
proportion of azithromycin resistance in typhoidal Salmonella in this study was 1.2% (13 of
1,082), and the strains used in this study were derived from a tertiary-level hospital in-patient
setting. Thus, it is not possible to predict the proportion of azithromycin resistance cases in the
community, where most typhoid cases are treated. Azithromycin resistance rates would also
differ in other countries, or between rural vs urban sites within Bangladesh. Furthermore, even
though we followed the latest CLSI guidelines [34], we are unable to assess the clinical implica-
tion of this mutation as comprehensive clinical and treatment history of the patients was not
available. On the other hand, there have been reports of azithromycin treatment failure, but
there is no genomic data to further investigate those cases.
With the dearth of novel antimicrobials on the horizon, we risk losing our primary defense
against widespread mortality from enteric fever and falling back into the pre-antibiotic era. In
2018, the first typhoid conjugate vaccine was prequalified, and endemic countries are now fac-
ing important decisions regarding its introduction. Considering the high burden of typhoid,
and the rising AMR crisis, introduction of the vaccine is speculated to decrease the burden,
which in turn, is expected to reduce AMR infections and thus overall use of antibiotics as
typhoid is the most common cause of bloodstream infection infections in endemic countries
[51]. However, the vaccine does not protect against paratyphoid, for which AMR is an equally
important issue to address. In addition to the roll-out of the vaccine in endemic areas, intro-
duction of water, sanitation and hygiene interventions, antibiotic stewardship and continued
AMR surveillance will also be very important to decrease the overall burden of enteric fever
and tackle the arms race against rising resistance.
Supporting information
S1 Fig. Spatiotemporal distribution of azithromycin-resistant Salmonella Typhi and Para-
typhi A strains. The 13 azithromycin-resistant typhoidal Salmonella strains were isolated
from Dhaka Shishu Hospital (shown in red). All the patients lived within the Dhaka municipal
area. The map was made using the R packages maptools and raster.
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S2 Fig. Genetic and structural analysis of 2 other non-synonymous SNPs. (A) SNP on
sty2741 gene (also known as purN) that encodes a glycinamidine ribonucleotide transformyl-
transferase (GAR-Tfase) enzyme. The SNP leads to change in W195 to a stop codon, leading
to premature termination of the protein sequence (highlighted in yellow). The structure of E.
coli GAT-Tfase (green, PDB ID: 1C3E) in complex with an inhibitor (shown in red) highlight-
ing the active site is shown. The W195 is present close to the C-terminus and premature termi-
nation at this position is predicted to not affect protein function (B) SNP on sty1399 that
encodes a hypothetical protein that is proposed to contain a B3/B4 tRNA-binding domain.
The function of this protein is not known and the SNP results in conversion of an alanine resi-
due at position 34 to a threonine residue (highlighted in yellow). None of these two genes have
been previously implicated in macrolide resistance.
(TIFF)
S3 Fig. Salmonella Paratyphi A strain 3144 belongs to lineage C4. To identify the lineage of
azithromycin resistant strain 3144, it was compared to 139 Paratyphi A strains from different
parts of the world. Whole genome SNP tree was made using RAxML and visualized in ggtree.
The lineage information was obtained from Britto et al. [6] and Kuijpers et al. [37] and shown
as the ring around the tree.
(TIFF)
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S1 Table. Characteristics of Salmonella Typhi and Paratyphi A isolates reported in the
study.
(XLSX)
S2 Table. AcrB mutations do not affect efflux of other families of antibiotics. Susceptibility
of E. coli strains with empty, Salmonella Typhi AcrB WT/R717Q and Paratyphi A AcrB WT/
R717L were tested against a panel of 9 different antibiotic including 5 beta-lactams, 2 fluoro-
quinolones, 1 phenicol and 1 diaminopyrimidine /sulphonamide. The data are shown as mean
and standard error from 3 different biological replicates.
(XLSX)
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